Shannon K. Parr
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shannon K. Parr has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Carl J. Ade
Kansas State University, College of Health and Human Sciences, School of Health Sciences, Kinesiology, Manhattan, KS, USA
4 shared publications - Stephen T. Hammond
Division of Cardiovascular Medicine, Department of Medicine (S.T.H., L.B., D.L., A.M.B.), Medical College of Wisconsin, Milwaukee
4 shared publications - Vanessa Rose G. Turpin
Department of Kinesiology, College of Health and Human Sciences, Kansas State University, USA
4 shared publications - Britton C. Scheuermann
College of Health and Human Sciences, Kansas State University, Manhattan, KS, USA
2 shared publications - Heather R. Banister
Department of Kinesiology, College of Health and Human Sciences, Kansas State University, Manhattan, USA
2 shared publications - Alec L. E. Butenas
University of Florida
1 shared publication
Latest Publications
- Open Access
- 17 November 2023
- Published by Elsevier in IJC Heart & Vasculature
- Vol. 49, 101300
Impaired microvascular reactivity in patients treated with 5-fluorouracil chemotherapy regimens: Potential role of endothelial dysfunction
- 17 November 2023
- Published by Elsevier in IJC Heart & Vasculature
- Vol. 49, 101300
Open AccessImpaired microvascular reactivity in patients treated with 5-fluorouracil chemotherapy regimens: Potential role of endothelial dysfunction
- 19 December 2022
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 31 (1) , 1-10
Inorganic nitrate supplementation may improve diastolic function and the O2 cost of exercise in cancer survivors: a pilot study
In non-cancer populations, inorganic dietary nitrate (NO3−) supplementation is associated with enhanced cardiorespiratory function but remains untested in patients with a history of cancer. Therefore, this pilot study sought to determine if oral NO3− supplementation, as a supportive care strategy, increases left ventricular (LV) function and exercise performance in survivors of cancer treated with anticancer therapy while simultaneously evaluating the feasibility of the methods and procedures required for future large-scale randomized trials. Two cohorts of patients with a history of cancer treated with anticancer chemotherapy were recruited. Patients in cohort 1 (n = 7) completed a randomized, double-blind, crossover study with 7 days of NO3− or placebo (PL) supplementation, with echocardiography. Similarly, patients in cohort 2 (n = 6) received a single, acute dose of NO3− supplementation or PL. Pulmonary oxygen uptake (VO2), arterial blood pressure, and stroke volume were assessed during exercise. In cohort 1, NO3− improved LV strain rate in early filling (mean difference (MD) [95% CI]: − 0.3 1/s [− 0.6 to 0.06]; P = 0.04) and early mitral septal wall annular velocity (MD [95% CI]: 0.1 m/s [− 0.01 to − 0.001]; P = 0.02) compared to placebo. In cohort 2, NO3− decreased the O2 cost of low-intensity steady-state exercise (MD [95% CI]: − 0.5 ml/kg/min [− 0.9 to − 0.09]; P = 0.01). Resting and steady-state arterial blood pressure and stroke volume were not different between conditions. No differences between conditions for peak VO2 (MD [95% CI]: − 0.7 ml/kg/min [− 3.0 to 1.6]; P = 0.23) were observed. The findings from this pilot study warrant further investigation in larger clinical trials targeting the use of long-term inorganic dietary NO3− supplementation as a possible integrative supportive care strategy in patients following anticancer therapy.
- 19 December 2022
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 31 (1) , 1-10
Inorganic nitrate supplementation may improve diastolic function and the O2 cost of exercise in cancer survivors: a pilot study
In non-cancer populations, inorganic dietary nitrate (NO3−) supplementation is associated with enhanced cardiorespiratory function but remains untested in patients with a history of cancer. Therefore, this pilot study sought to determine if oral NO3− supplementation, as a supportive care strategy, increases left ventricular (LV) function and exercise performance in survivors of cancer treated with anticancer therapy while simultaneously evaluating the feasibility of the methods and procedures required for future large-scale randomized trials. Two cohorts of patients with a history of cancer treated with anticancer chemotherapy were recruited. Patients in cohort 1 (n = 7) completed a randomized, double-blind, crossover study with 7 days of NO3− or placebo (PL) supplementation, with echocardiography. Similarly, patients in cohort 2 (n = 6) received a single, acute dose of NO3− supplementation or PL. Pulmonary oxygen uptake (VO2), arterial blood pressure, and stroke volume were assessed during exercise. In cohort 1, NO3− improved LV strain rate in early filling (mean difference (MD) [95% CI]: − 0.3 1/s [− 0.6 to 0.06]; P = 0.04) and early mitral septal wall annular velocity (MD [95% CI]: 0.1 m/s [− 0.01 to − 0.001]; P = 0.02) compared to placebo. In cohort 2, NO3− decreased the O2 cost of low-intensity steady-state exercise (MD [95% CI]: − 0.5 ml/kg/min [− 0.9 to − 0.09]; P = 0.01). Resting and steady-state arterial blood pressure and stroke volume were not different between conditions. No differences between conditions for peak VO2 (MD [95% CI]: − 0.7 ml/kg/min [− 3.0 to 1.6]; P = 0.23) were observed. The findings from this pilot study warrant further investigation in larger clinical trials targeting the use of long-term inorganic dietary NO3− supplementation as a possible integrative supportive care strategy in patients following anticancer therapy.
- Open Access
- 1 June 2021
- Published by Elsevier in International Journal of Cardiology Hypertension
- Vol. 9, 100085
Arterial stiffness is associated with cardiovascular and cancer mortality in cancer patients: Insight from NHANESIII
- 1 June 2021
- Published by Elsevier in International Journal of Cardiology Hypertension
- Vol. 9, 100085
Open AccessArterial stiffness is associated with cardiovascular and cancer mortality in cancer patients: Insight from NHANESIII
- Open Access
- 13 May 2021
- Published by Springer Nature in Cardio-Oncology
- Vol. 7 (1) , 1-8
Lower endothelium-dependent microvascular function in adult breast cancer patients receiving radiation therapy
Purpose: Cancer patients with a history of radiotherapy are at an increased risk of ischemic heart disease. Preclinical animal studies demonstrate markedly impaired acetylcholine (ACh)-mediated endothelium-dependent vasorelaxation within days to weeks post-irradiation, however, whether microvascular function is affected in the intact human circulation during cancer radiation therapy has yet to be determined. Materials and methods: Using laser-Doppler flowmetry, microvascular endothelium-dependent and independent responses were evaluated through iontophoresis of acetylcholine (ACh) (part 1, n = 7) and sodium nitroprusside (SNP) (part 2, n = 8), respectively, in women currently receiving unilateral chest adjuvant radiation therapy for breast cancer. Measurements were performed at the site of radiation treatment and at a contralateral control, non-radiated site. Cutaneous vascular conductance (CVC) was calculated by normalizing for mean arterial pressure. Results and Conculsions: In part 1, patients received an average radiation dose of 2104 ± 236 cGy. A significantly lower peak ACh-mediated endothelium-dependent vasodilation was observed within the radiated microvasculature when compared to non-radiated (radiated: 532 ± 167%, non-radiated 1029 ± 263%; P = 0.02). In part 2, the average radiation dose received was 2251 ± 196 cGy. Iontophoresis of SNP elicited a similar peak endothelium-independent vasodilator response in radiated and non-radiated tissue (radiated: 179 ± 58%, non-radiated: 310 ± 158; P = 0.2). The time to 50% of the peak response for ACh and SNP was similar between radiated and non-radiated microvasculature (P < 0.05). These data provide evidence of early endothelium-dependent microvascular dysfunction in cancer patients currently receiving chest radiation and provide the scientific premise for future work evaluating coronary endothelial function and vasomotor reactivity using more detailed and invasive procedures.
- 13 May 2021
- Published by Springer Nature in Cardio-Oncology
- Vol. 7 (1) , 1-8
Open AccessLower endothelium-dependent microvascular function in adult breast cancer patients receiving radiation therapy
Purpose: Cancer patients with a history of radiotherapy are at an increased risk of ischemic heart disease. Preclinical animal studies demonstrate markedly impaired acetylcholine (ACh)-mediated endothelium-dependent vasorelaxation within days to weeks post-irradiation, however, whether microvascular function is affected in the intact human circulation during cancer radiation therapy has yet to be determined. Materials and methods: Using laser-Doppler flowmetry, microvascular endothelium-dependent and independent responses were evaluated through iontophoresis of acetylcholine (ACh) (part 1, n = 7) and sodium nitroprusside (SNP) (part 2, n = 8), respectively, in women currently receiving unilateral chest adjuvant radiation therapy for breast cancer. Measurements were performed at the site of radiation treatment and at a contralateral control, non-radiated site. Cutaneous vascular conductance (CVC) was calculated by normalizing for mean arterial pressure. Results and Conculsions: In part 1, patients received an average radiation dose of 2104 ± 236 cGy. A significantly lower peak ACh-mediated endothelium-dependent vasodilation was observed within the radiated microvasculature when compared to non-radiated (radiated: 532 ± 167%, non-radiated 1029 ± 263%; P = 0.02). In part 2, the average radiation dose received was 2251 ± 196 cGy. Iontophoresis of SNP elicited a similar peak endothelium-independent vasodilator response in radiated and non-radiated tissue (radiated: 179 ± 58%, non-radiated: 310 ± 158; P = 0.2). The time to 50% of the peak response for ACh and SNP was similar between radiated and non-radiated microvasculature (P < 0.05). These data provide evidence of early endothelium-dependent microvascular dysfunction in cancer patients currently receiving chest radiation and provide the scientific premise for future work evaluating coronary endothelial function and vasomotor reactivity using more detailed and invasive procedures.